蚜菌灵
生物
立体化学
对接(动物)
DNA
DNA聚合酶
生物化学
化学
医学
护理部
作者
Siwen Niu,Jin‐Mei Xia,Zengpeng Li,Longhe Yang,Zhiwei Yi,Chun‐Lan Xie,Guizhen Peng,Zhu-Hua Luo,Zongze Shao,Xian‐Wen Yang
标识
DOI:10.1021/acs.jnatprod.9b00705
摘要
Aphidicolin, a potent DNA polymerase α inhibitor, has been explored in clinical trials for the treatment of cancer. So far, about 300 modified aphidicolins have been discovered. However, none have shown a stronger effect. Herein, we report 71 new (aphidicolins A1–A71, 1–71) and eight known (72–79) aphidicolin congeners from Botryotinia fuckeliana MCCC 3A00494, a fungus isolated from the western Pacific Ocean (−5572 m). The structures of 1–71 were determined through extensive spectroscopic analysis, X-ray crystallography, chemical derivatization, modified Mosher's method, and the ECD exciton chirality method. Compounds 54–57 and 58–64 are novel 6/6/5/6/5 pentacyclic aphidicolins featuring tetrahydrofuran and dihydrofuran rings, respectively, while compounds 65–71 are rare noraphidicolins. Aphidicolin A8 (8) significantly induced apoptosis in T24 (IC50 = 2.5 μM) and HL-60 (IC50 = 6.1 μM) cancer cells by causing DNA damage. By docking its structure to the human DNA polymerase α binding pocket, 8 was found to form tight intermolecular contacts, elaborating aphidicolin A8 as a potently cytotoxic lead compound.
科研通智能强力驱动
Strongly Powered by AbleSci AI